Smith Nicholas Conrad Insider Trades & Stock Holdings

PRESIDENT AND CFO · Alto Neuroscience, Inc. · Latest filing Sep 30, 2026

Smith Nicholas Conrad, PRESIDENT AND CFO at Alto Neuroscience, Inc. has 2 Form 4 trades on file since Sep 29, 2026. Open-market activity: 0 purchases ($0) and 2 sales ($3.57M), net -$3.57M. Latest filing: disposed of 24.06K shares of $ANRO on Sep 30, 2026 at $25.82.

Trades on file

2

Open-market bought

$0

Open-market sold

$3.57M

Net open-market

-$3.57M

Latest filing

Sep 30, 2026

All insider trades by Smith Nicholas Conrad

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Sep 30, 2026	$ANRO	Sell (Open-market sale) 10b5-1	24.06K	$25.82	$621.10K						PRESIDENT AND CFO		—
Sep 29, 2026	$ANRO	Sell (Open-market sale) 10b5-1	110.83K	$26.58	$2.95M						PRESIDENT AND CFO		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Smith Nicholas Conrad traded

• $ANRO

Frequently asked questions

Has Smith Nicholas Conrad been buying or selling stock?

Smith Nicholas Conrad has 0 open-market purchases and 2 open-market sales on file, net -$3.57M. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Smith Nicholas Conrad's latest insider trade?

disposed of 24.06K shares of $ANRO on Sep 30, 2026 at $25.82.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.